Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2014-2020
Figure 4-2: Genetic Testing Market by Geography (%), 2014
Figure 4-3: Genetic Testing Market by Geography (%), 2020
Figure 7-1: Number of Disorders, Genes, Labs, & Clinics for Genetic Testing (2014 & 2015)
Figure 7-2: Number of Genetic Tests Performed (2013-2015)
Figure 7-3: US - Genetic Testing Market (Billion US$), 2014-2020
Figure 7-4: Europe - Genetic Testing Market (Billion US$), 2014-2020
Figure 7-5: Asia-Pacific - Genetic Testing Market (Million US$), 2014-2020
Figure 8-1: Global - Next Generation Sequencing Market (Billion US$), 2014-2020
Figure 8-2: Global - NGS Application by Sector (%)
Figure 8-3: Global - Next Generation Sequencing Market by Player (%), 2013
Figure 8-4: Global - Non-Invasive Prenatal Testing Market (Million US$), 2014-2020
Figure 8-5: US - Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 8-6: US - Personalized Cancer WGS Market (Million US$), 2014-2020
Figure 8-7: Organizational Transformation to Support Personalized Medicine
Figure 9-1: Genetic Testing Regulatory Agencies
Figure 10-1: Abbott Laboratories - Revenue Breakup by Segments (%), 2014
Figure 10-2: Abbott Laboratories - Revenue Breakup by Geography (%), 2014
Figure 10-3: Roche Holding - Revenue Breakup by Segments (%), 2014
Figure 10-4: Roche Holding - Diagnostic Division Revenue by Geography (%), 2014
Figure 10-5: Myriad Genetics - Revenue Breakup by Segments (%), 2014
Figure 10-6: Life Technologies - Revenue Breakup by Segments (%), 2014
Figure 10-7: Life Technologies - Revenue Breakup by Geography (%), 2014
Figure 10-8: Agilent - Revenue Breakup by Segments (%), 2014
Figure 10-9: Hologic - Revenue Breakup by Segments (%), 2014
Figure 10-10: Hologic - Revenue Breakup by Geography (%), 2014
Figure 10-11: Illumina - Revenue Breakup by Geography (%), 2014
Figure 10-12: Qiagen NV - Revenue Break up by Segments (%), 2014
Figure 10-13: Qiagen NV - Revenue Break up by Geography (%), 2014
Figure 10-14: Cepheid - Revenue Break up by Segments (%), 2014
Figure 10-15: Cepheid - Revenue Break up by Geography (%), 2014
Figure 10-16: Affymetrix - Revenue Breakup by Segments (%), 2014
Figure 10-17: Affymetrix - Revenue Breakup by Geography (%), 2014

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment
Table 7-1: FDA Approved Pharmacogenomic Biomarkers for Oncology
Table 9-1: Abbott Laboratories - Key Gene Based Products
Table 9-2: Abbott Laboratories - Financial Performance (Million US$), 2012-2014
Table 9-3: Roche Molecular Diagnostics - Key Gene Based Products
Table 9-4: Roche Holding - Financial Performance (Million US$), 2012-2014
Table 9-5: Myriad Genetics - Key Gene Based Products
Table 9-6: Myriad Genetics - Financial Performance (Million US$), 2012-2014
Table 9-7: Life Technologies - Key Gene Based Products
Table 9-8: Life Technologies - Financial Performance (Million US$), 2012-2014
Table 9-9: Agilent - Key Gene Based Products
Table 9-10: Agilent - Financial Performance (Million US$), 2012-2014
Table 9-11: Hologic - Key Gene Based Products
Table 9-12: Hologic - Financial Performance (Million US$), 2012-2014
Table 9-13: Illumina - Key Gene Based Products
Table 9-14: Illumina - Financial Performance (Million US$), 2012-2014
Table 9-15: Qiagen NV - Key Gene Based Products
Table 9-16: Qiagen NV - Financial Performance (Million US$), 2012-2014
Table 9-17: Cepheid - Key Gene Based Products
Table 9-18: Cepheid - Financial Performance (Million US$), 2012-2014
Table 9-19: Affymetrix - Key Gene Based Products
Table 9-20: Affymetrix - Financial Performance (Million US$), 2012-2014